Does ENCORAFENIB Cause Skin hyperpigmentation? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Skin hyperpigmentation have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.1% of all adverse event reports for ENCORAFENIB.
8
Reports of Skin hyperpigmentation with ENCORAFENIB
0.1%
of all ENCORAFENIB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Skin hyperpigmentation From ENCORAFENIB?
Of the 8 reports, 1 (12.5%) resulted in death, 4 (50.0%) required hospitalization.
Is Skin hyperpigmentation Listed in the Official Label?
Yes, Skin hyperpigmentation is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Skin hyperpigmentation?
ADAPALENE (2,811)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (2,277)
BIMATOPROST (189)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (182)
DUPILUMAB (177)
MINOCYCLINE (144)
LENALIDOMIDE (142)
METHOTREXATE (142)
CAPECITABINE (136)
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES (120)
Which ENCORAFENIB Alternatives Have Lower Skin hyperpigmentation Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN